KLOW Blend

The KLOW Blend is a sophisticated, synergistic research formulation engineered to amplify soft-tissue regeneration and systemic metabolic recovery. While proprietary in exact stoichiometry, this blend is designed to target the primary inflammatory cascades (IL-6, CRP) and enhance macrophage polarization from the pro-inflammatory M1 phenotype to the pro-healing M2 phenotype. It simultaneously promotes angiogenesis via upregulation of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Research applications focus on accelerated healing of chronic ulcers, post-surgical tissue remodeling, and reducing fibrosis in injured muscles. The blend’s synergistic effect ensures that the individual peptides work in a cascade, where one compound primes the cellular environment while the other facilitates ECM deposition. Researchers are advised to handle this blend with care, as its complex structure requires gentle reconstitution and immediate use to maintain the integrity of its multi-peptide matrix.